Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MTNB

Matinas BioPharma

$0.97

-0.17 (-14.91%)

, AMRN

Amarin

$19.83

-1.2 (-5.71%)

07:47
11/13/18
11/13
07:47
11/13/18
07:47
Recommendations
Matinas BioPharma, Amarin analyst commentary at Maxim »

Matinas BioPharma price…

MTNB

Matinas BioPharma

$0.97

-0.17 (-14.91%)

AMRN

Amarin

$19.83

-1.2 (-5.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
MTNB

Matinas BioPharma

$1.01

0.1287 (14.69%)

16:38
11/08/18
11/08
16:38
11/08/18
16:38
Hot Stocks
Breaking Hot Stocks news story on Matinas BioPharma »

Boxer Capital reports 7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTNB

Matinas BioPharma

$0.79

-0.0462 (-5.53%)

08:59
10/18/18
10/18
08:59
10/18/18
08:59
Hot Stocks
Matinas BioPharma announces issuance of U.S. patent for MAT9001 »

Matinas BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTNB

Matinas BioPharma

$0.82

0.0363 (4.63%)

08:38
10/15/18
10/15
08:38
10/15/18
08:38
Hot Stocks
Matinas BioPharma appoints Theresa Matkovits as CDO »

Matinas BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTNB

Matinas BioPharma

$0.55

0.1392 (33.98%)

, AMRN

Amarin

$11.62

8.62 (287.33%)

15:03
09/24/18
09/24
15:03
09/24/18
15:03
Recommendations
Matinas BioPharma, Amarin analyst commentary at Maxim »

Amarin's Vascepa…

MTNB

Matinas BioPharma

$0.55

0.1392 (33.98%)

AMRN

Amarin

$11.62

8.62 (287.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 01

    Oct

MTNB

Matinas BioPharma

$0.46

0.0501 (12.23%)

, AMRN

Amarin

$9.99

6.99 (233.00%)

12:24
09/24/18
09/24
12:24
09/24/18
12:24
Hot Stocks
Matinas spikes as MAT9001 gains attention after Amarin data »

Shares of Matinas…

MTNB

Matinas BioPharma

$0.46

0.0501 (12.23%)

AMRN

Amarin

$9.99

6.99 (233.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 01

    Oct

Over a quarter ago
CFRX

ContraFect

$1.90

(0.00%)

, MTNB

Matinas BioPharma

$0.41

0.0024 (0.59%)

08:25
08/22/18
08/22
08:25
08/22/18
08:25
Conference/Events
FDA to hold a public workshop »

The FDA holds a two day…

CFRX

ContraFect

$1.90

(0.00%)

MTNB

Matinas BioPharma

$0.41

0.0024 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

CFRX

ContraFect

$1.90

(0.00%)

, MTNB

Matinas BioPharma

$0.41

0.0024 (0.59%)

04:55
08/22/18
08/22
04:55
08/22/18
04:55
Conference/Events
FDA to hold a public workshop »

The FDA holds a two day…

CFRX

ContraFect

$1.90

(0.00%)

MTNB

Matinas BioPharma

$0.41

0.0024 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

CFRX

ContraFect

, MTNB

Matinas BioPharma

16:34
08/21/18
08/21
16:34
08/21/18
16:34
Conference/Events
FDA to hold a public workshop »

The FDA holds a two day…

CFRX

ContraFect

MTNB

Matinas BioPharma

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

CFRX

ContraFect

$1.90

-0.06 (-3.06%)

, MTNB

Matinas BioPharma

$0.41

0.045 (12.50%)

08:20
08/21/18
08/21
08:20
08/21/18
08:20
Conference/Events
FDA to hold a public workshop »

The FDA holds a two day…

CFRX

ContraFect

$1.90

-0.06 (-3.06%)

MTNB

Matinas BioPharma

$0.41

0.045 (12.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.